Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study).

Author: AdlerScott, BardinThomas, BaumgartnerScott, BhaktaNihar, FungMaple, KeenanRobert T, KhannaPuja P, KopickoJeff, SoAlexander, StorgardChris

Paper Details 
Original Abstract of the Article :
OBJECTIVES: Determine the efficacy and safety of daily lesinurad (200 or 400 mg orally) added to allopurinol in patients with serum uric acid (sUA) above target in a 12-month, randomised, phase III trial. METHODS: Patients on allopurinol ≥300 mg (≥200 mg in moderate renal impairment) had sUA level ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530336/

データ提供:米国国立医学図書館(NLM)

The Effectiveness of Lesinurad in Combination with Allopurinol for Gout Treatment

The field of gout treatment is constantly evolving, with researchers seeking ways to improve the management of this painful condition. This study dives deep into the effectiveness and safety of combining lesinurad with allopurinol, a common treatment for gout. The study employed a randomized, double-blind, placebo-controlled design to compare the efficacy of different doses of lesinurad against a standard allopurinol-alone therapy in patients with gout. The researchers meticulously tracked the patients' serum uric acid levels and gout flare rates over a 12-month period. They discovered that adding lesinurad to allopurinol significantly reduced serum uric acid levels compared to allopurinol alone. This finding suggests that lesinurad could be a valuable addition to the treatment arsenal for patients with gout who aren't responding well to standard therapy.

Lesinurad: A Promising Addition to Gout Management

The results of this study are quite promising. Adding lesinurad, especially at the 200 mg dose, to allopurinol significantly improved the proportion of patients achieving their target serum uric acid levels within six months. This suggests that lesinurad could be a valuable option for patients who struggle to manage their gout with allopurinol alone. The researchers observed that lesinurad was generally well-tolerated, particularly at the 200 mg dose, with a safety profile comparable to allopurinol alone.

Gout Management: A Balancing Act

While lesinurad shows promise, it's important to remember that any medication comes with potential side effects. This study observed that higher doses of lesinurad were associated with a greater risk of renal-related adverse events, including elevated serum creatinine levels. It's crucial for patients to discuss their individual risk factors and potential side effects with their healthcare providers to determine the best treatment approach.

Dr. Camel's Conclusion

Think of gout like a stubborn camel refusing to budge from a pile of prickly desert plants. Lesinurad acts like a gentle nudge, helping to dislodge those crystals and bring relief. However, like the delicate balance of a camel's gait in the desert, finding the right dose of lesinurad is key to achieving optimal results without unwanted side effects. It's important to consult a doctor, as they'll help you find the perfect balance for your own journey to gout management.

Date :
  1. Date Completed 2017-06-13
  2. Date Revised 2022-04-09
Further Info :

Pubmed ID

27821644

DOI: Digital Object Identifier

PMC5530336

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.